I, too, hope you are correct. I tend to believe

I, too, hope you are correct.

I tend to believe that the Severe-Critical has a better chance at approval. The Mild-Moderate seems entirely dependent on the notion that good labs are directly correlated to favorable clinical outcomes. I would hope that would hold true, but I am concerned that the placebo arm might be largely populated with Mild patients (as opposed to Moderate) who may recover on their own.

After the past couple of months, I don't trust the FDA, NIH, Fauci or Big Pharma. I know others feel differently, and that's fine. However, you don't have to wear a tin foil hat to recognize that this country has a bad case of Big Pharma favoritism.

There are those who believe the FDA is 'playing us' with the EINDs and M-M trial in an effort to slow us down for various nefarious reasons -- not the least of which may be the projected $7.7B Gilead might earn from COVID.
https://www.bloomberg.com/news/articles/2020-...-7-billion

If that were to happen, I would hope that we'd at least receive an approval from Mexico, which would likely open up Latin America, but probably not the UK or EU. It would be great to start saving lives, as all lives are precious. However, it is worth nothing that from a purely commercial point-of-view, there is significant pricing pressure from less affluent countries. Notwithstanding, validation of any kind would be great, and would likely start a progression that gets us where we need to be.

IMO